Outcomes of Infection and Risk of Mortality in Liver Transplant Patients with Simultaneous Splenectomy

J Gastrointest Surg. 2021 Oct;25(10):2524-2534. doi: 10.1007/s11605-021-04914-5. Epub 2021 Feb 18.

Abstract

Purpose: The purpose of this study was to compare the outcomes of infection between liver transplant patients with and without simultaneous splenectomy.

Methods: We retrospectively analyzed the records of 211 patients who underwent liver transplantation in the Tri-Service General Hospital from 2012 to 2017. The frequency of blood cultures obtained after liver transplantation; incidence of bacteremia, pathogens, and complications; and overall survival rates were compared between the groups.

Results: One hundred thirty-three of 211 patients underwent liver transplantation without simultaneous splenectomy. There were no significant differences in the frequency of blood cultures obtained after liver transplantation (non-splenectomy group and splenectomy group: 63% and 62%, respectively); incidences of bacteremia after liver transplantation (21% and 21%, respectively), repeat bacteremia (39% and 35%, respectively), cytomegalovirus infection (4% and 3%, respectively), herpes infection (6% and 7%, respectively), and fungal infection (3% and 3%, respectively); and overall survival rate between the two groups. However, there was a significant difference in infection-related deaths between the groups. Simultaneous splenectomy and episodes of antibody-related rejection were significant risk factors associated with infection-related death in multivariate analyses.

Conclusion: Although simultaneous splenectomy does not increase the incidence of infection, simultaneous splenectomy definitely carries risks of infection-related mortality in liver transplantation.

Keywords: Infectious disease; Liver transplantation; Spleen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Incidence
  • Liver Transplantation* / adverse effects
  • Retrospective Studies
  • Risk Factors
  • Splenectomy / adverse effects